{"url_path":"/sec/uthr/8-k/2026-06-29/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001104659-26-078865-index.html","accession_number":"0001104659-26-078865","cik":"0001082554","ticker":"UTHR","issuer_name":"UNITED THERAPEUTICS Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001104659-26-078865-index.html","primary_entity_key":"0001082554","primary_entity_name":"UNITED THERAPEUTICS Corp"},"word_count":213,"has_tables":true,"body_markdown":"**Item 5.07.**\n**Submission of Matters to a Vote of Security Holders.**\n\n \n\nOn June 26, 2026, the Company held its 2026 Annual Meeting of\nShareholders. The Company’s shareholders considered four matters, each of which is described in more detail in the Proxy Statement.\nThe final voting results for the meeting are as follows:\n\n \n\n1.Election of directors, each to serve a term of one year:\n\n \n\nNominee \nVotes For  \nVotes Against  \nAbstentions  \nBroker\nNon-Votes \n\nChristopher Causey \n 32,342,983  \n 3,861,566  \n 14,328  \n 1,194,857 \n\nRichard Giltner \n 33,029,828  \n 3,174,662  \n 14,387  \n 1,194,857 \n\nRay Kurzweil \n 35,215,793  \n 988,979  \n 14,105  \n 1,194,857 \n\nJan Malcolm \n 35,912,588  \n 292,981  \n 13,308  \n 1,194,857 \n\nLinda Maxwell \n 35,472,607  \n 725,977  \n 20,293  \n 1,194,857 \n\nNilda Mesa \n 35,477,452  \n 715,174  \n 26,251  \n 1,194,857 \n\nJudy Olian \n 35,661,334  \n 543,343  \n 14,200  \n 1,194,857 \n\nChristopher Patusky \n 32,649,292  \n 3,555,219  \n 14,366  \n 1,194,857 \n\nMartine Rothblatt \n 34,492,974  \n 1,713,789  \n 12,114  \n 1,194,857 \n\nLouis Sullivan \n 33,409,607  \n 2,794,332  \n 14,938  \n 1,194,857 \n\nTommy Thompson \n 35,012,786  \n 1,192,155  \n 13,936  \n 1,194,857 \n\nKevin Tracey \n 36,187,554  \n 18,239  \n 13,084  \n 1,194,857 \n\n \n\n2\n\n \n\n \n\n2.An advisory resolution to approve executive compensation:\n\n \n\nVotes for: \n 35,152,059 \n\nVotes against: \n 1,048,505 \n\nAbstentions: \n 18,313 \n\nBroker non-votes: \n 1,194,857 \n\n \n\n3.Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan:\n\n \n\nVotes for: \n 25,872,075 \n\nVotes against: \n 10,070,290 \n\nAbstentions: \n 276,512 \n\nBroker non-votes: \n 1,194,857 \n\n \n\n4.Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm\nfor 2026:\n\n \n\nVotes for: \n 35,753,887 \n\nVotes against: \n 1,647,415 \n\nAbstentions: \n 12,432 \n\nBroker non-votes: \n —"}